Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations

Investor RelationsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Stock price graph
     

Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System

Ticker Symbol: SPPI

View all »   RSSRecent Releases

Jul 30, 2015
Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast

Jun 24, 2015
Spectrum Pharmaceuticals Announces Publication of Beleodaq® Data Selected as a Rapid Communication in the Journal of Clinical Oncology

View all »Events & Presentations

Aug 6, 2015 at 1:30 PM PT
Second Quarter 2015 Financial Results Conference Call

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
6.92
Change:
+ 0.15
Day High:
7.07
Day Low:
6.71
Volume:
625,100
4:00 PM ET on Jul 31, 2015
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company